arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 1903.04907q-bio.TO
收藏

使用市售心室辅助装置治疗Fontan腔静脉支持失败的风险和受益:一项建模研究

Risks and Benefits of Using a Commercially Available Ventricular Assist Device for Failing Fontan Cavopulmonary Support: A Modeling Investigation

Masoud Farahmand, Minoo N. Kavarana, Ethan O. Kung

摘要:

Fontan患者通常会出现循环衰竭,迫切需要治疗方案。通过外科手术将血泵放置在腔静脉通路中,可以通过产生轻微的升压来替代缺失的肺下心室的功能。然而,目前还没有设计用于腔静脉应用的市售器械;在Fontan衰竭患者的右循环中植入最初设计用于左心室应用的心室辅助器械(VAD)的风险和受益尚不清楚。此外,还需要进一步研究来比较两种临床上考虑的腔静脉辅助手术配置(完全支持和IVC支持)之间的血流动力学,完全和IVC支持分别对应于整个静脉回流或仅下方静脉回流,通过VAD进行路由。在这项研究中,我们使用了失败的Fontan生理学的数值模型,以评价在IVC和完全支持期间对左VAD的Fontan血流动力学反应。我们观察到,在完全支持期间,VAD改善了心输出量,同时将血压<动>维持在安全范围内,并将IVC压力降低至<15 mmHg;然而,我们发现由于肺压过度升高,在较高泵速下存在肺损伤的潜在风险。另一方面,IVC支持对Fontan失败患者的血液动力学没有益处,导致上腔静脉压力增加到>20 mmHg的不安全水平。本研究的发现可能有助于外科医生认识到腔静脉VAD的风险,并制定实施腔静脉支持的一致临床策略。

英文摘要:

Fontan patients often develop circulatory failure and are in desperate need of a therapeutic solution. A blood pump surgically placed in the cavopulmonary pathway can substitute the function of the absent sub-pulmonary ventricle by generating a mild pressure boost. However, there is currently no commercially available device designed for the cavopulmonary application; and the risks and benefits of implanting a ventricular assist device (VAD) originally designed for the left ventricular application on the right circulation of failing Fontan patients is not yet clear. Moreover, further research is needed to compare the hemodynamics between the two clinically-considered surgical configurations (Full Support and IVC Support) for cavopulmonary assist, with Full and IVC Support corresponding to the entire venous return or only the inferior venous return, respectively, being routed through the VAD. In this study, we used a numerical model of the failing Fontan physiology to evaluate the Fontan hemodynamic response to a left VAD during the IVC and Full supports. We observed that during the Full support the VAD improved the cardiac output while maintaining blood pressures within safe ranges, and lowered the IVC pressure to <15mmHg; however, we found a potential risk of lung damage at higher pump speeds due to the excessive pulmonary pressure elevation. IVC support the other hand, did not benefit the hemodynamics of the example failing Fontan patients, resulting in the superior vena cava pressure increasing to an unsafe level of >20 mmHg. The findings in this study may be helpful to surgeons for recognizing the risks of a cavopulmonary VAD and developing coherent clinical strategies for the implementation of cavopulmonary support.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑